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Parkinson's disease (PD) is a common age-associated neurodegenerative disorder. The protein α-synuclein
(aSyn) is a key factor in PD both due to its association with familial and sporadic cases and because it is the
main component of the pathological protein aggregates known as Lewy bodies. However, the precise
cellular effects of aSyn aggregation are still elusive. Here, we developed an elastomeric microfluidic device
equipped with a chemical gradient generator and 9 chambers containing cell traps to study aSyn produc-
tion and aggregation in Saccharomyces cerevisiae. This study involved capturing single cells, exposing
them to specific chemical environments and imaging the expression of aSyn by means of a GFP fusion
(aSyn-GFP). Using a galactose (GAL) gradient we modulated aSyn expression and, surprisingly, by tracking
the behavior of single cells, we found that the response of individual cells in a population to a given
stimulus can differ widely. To study the combined effect of environmental factors and aSyn expression
levels, we exposed cells to a gradient of FeCl3. We found a dramatic increase in the percentage of cells
displaying aSyn inclusions from 27% to 96%. Finally, we studied the effects of ascorbic acid, an antioxidant,
on aSyn aggregation and found a significant reduction in the percentage of cells bearing aSyn inclusions
from 87% to 37%. In summary, the device developed here offers a powerful way of studying aSyn biology
with single-cell resolution and high throughput using genetically modified yeast cells.Introduction
The budding yeast Saccharomyces cerevisiae has been widely
explored as a model organism to investigate the molecular
underpinnings of several human diseases.1–3 This yeast is the
best-characterized eukaryotic cell, is easy to grow under defined
conditions, and can easily be genetically manipulated.4,5
Parkinson's disease (PD) is a neurodegenerative disorder
characterized by the loss of dopaminergic neurons in the
substantia nigra in the brain and by the accumulation of
intraneuronal protein deposits known as Lewy bodies.6
Although the precise molecular mechanisms underlying PD
are still elusive, the identification of genes causing familial
forms of the disease enabled significant advances in ourunderstanding of the disease.7 The SNCA gene was the first
to be associated with familial forms of PD and encodes
for α-synuclein (aSyn), the main protein component of Lewy
bodies.6,8,9 However, it is currently unclear whether aggre-
gated forms of aSyn are toxic or, instead, neuroprotective.10,11
To investigate the basic molecular effects of aSyn in the
context of a living cell, human aSyn was expressed in yeast
and found to induce dose-dependent cytotoxicity.12 Using
GFP as a reporter and the galactose (GAL)-inducible pro-
moter, aSyn-GFP fusions were found to initially associate
with the plasma membrane and then to accumulate in cyto-
plasmic inclusions reminiscent of protein aggregates.12
Several additional studies followed, exploiting this yeast
model for high-throughput analyses that proved instrumental
in informing on the molecular mechanisms involved in aSyn
toxicity.13–16
Microfluidics technology, relying on transparent elasto-
meric materials such as polydimethylsiloxane (PDMS), has
made it possible to quickly develop prototypes of devices
appropriate for cell culture and live-cell imaging.17 Micro-
fluidic devices offer the possibility of performing biological
experiments with small amounts of reagents while still being
able to parallel process tens or hundreds of experiments in a
very small area.17,18 Since in microfluidic channels liquids, 2014, 14, 3949–3957 | 3949
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View Article Onlineflow in the laminar regime19,20 it is possible to generate
microenvironments with specific chemical compositions and
expose individual cells within a given population to these
environments.21
Although classical cell culture protocols enable the study
of populations of cells exposed to different chemical stimuli
over time, difficulties arise when it is necessary to achieve
single-cell resolution. Single-cell studies are important for
following the response of individual cells to a static or
changing environment over time. Currently used cell culture
and cell separation techniques do not allow the continuous
tracking of hundreds of individual cells simultaneously in an
efficient way. Moreover, single-cell tracking in culture is
particularly difficult for non-adherent cells such as yeast.
Several methods for trapping cells in microfluidic devices
have been described,22 but the most straightforward relies on
placing arrays of physical traps in the streamlines of cells in
suspension flowing in the device and allows the isolation and
immobilization of single cells.23
In addition to the trapping of cells, microenvironments
with specific chemical formulations and high spatial resolu-
tion can also be created in microfluidics by using gradient
generators.24,25 This type of device is able to produce a stable
chemical gradient with a predictable profile and offers poten-
tial for high parallelization.
In this study, we developed a device consisting of a micro-
fluidic gradient generator coupled to 9 chambers containing
an array of cell traps (Fig. 1A–C). By capturing genetically
modified yeast cells expressing aSyn-GFP under the control of
a GAL-inducible promoter, we were able to tightly modulate
aSyn-GFP expression using a gradient of GAL. We were also
able to follow the evolution of aSyn production inside indi-
vidual immobilized cells. As a proof of concept, we used the
same device to determine the effect of FeCl3, a chemical
stressor, and of ascorbic acid, an antioxidant, on aSyn inclu-
sion formation. In summary, the device developed here con-
stitutes a powerful platform for high-throughput screens for
drug discovery, enabling the simultaneous testing of a range
of compound concentrations. Furthermore, the single-cell
trapping capabilities offered by this device also enable single-
cell behavior analysis within a population when exposed to a
given chemical environment.3950 | Lab Chip, 2014, 14, 3949–3957
Fig. 1 Schematic overview of the microfluidic device. (A) Schematic o
(white arrow) and chambers with arrays of passive hydrodynamic cell traps
inlets (i, ii and iii) and cells are inserted through a fourth inlet (iv) that branc
mixing of two fluorescent fluids with different concentrations of FITC at
micrograph of cell traps in PDMS.Experimental
Mold fabrication
The device was fabricated using a variant of the rapid
prototyping and soft-lithography techniques, which relies on
using a master mold to build PDMS replicas.26,27 Since this
device has features on the order of a couple of micrometers,
the mold was made directly on top of the physical mask.
Briefly, the physical mask was made on a 25 mm × 50 mm
sample of glass (Corning, New York, USA) with a 1500–2000 Å
layer of AlSiCu deposited by sputtering. Patterning of the
metallic layer to the design of the microfluidic mold was
performed using standard photolithography and chemical
etching techniques. After the patterning of the AlSiCu, a first
layer of SU-8 2005 (MicroChem Corp., Newton, MA) was spin-
coated on top of the metallic side of the sample to a thick-
ness of about 5 μm and fully exposed. This first layer
provides a uniform surface and, given SU-8's poor adhesion
to glass, ensures that the small features of the device adhere
strongly to the substrate. A second layer of SU-8 2005 with
a thickness of about 9 μm was spin-coated on top of the first
layer. This SU-8 layer was then exposed through the glass side
of the sample with a UV flood lamp, so that only the SU-8 on
the patterned AlSiCu-free areas was cross-linked. The second
SU-8 layer was then developed in propylene glycol mono-
methyl ether acetate (Sigma-Aldrich) and hard baked at
150 °C for at least 20 min.Device fabrication
The devices were fabricated with PDMS (Dow Corning,
Midland, MI). PDMS with a 10 : 1 ratio (base to curing agent,
w/w) was poured on top of the SU-8 mold and cured at 70 °C
for 50 min. The molds were placed inside a custom-sized
poly(methyl methacrylate) case with 5 mm high internal
walls to allow for a consistent thickness of 5 mm between
batches. After curing, access ports were punched with a 20 ga
syringe tip (Instech, PA, USA). A sealing layer was made by
spin-coating PDMS with a 20 : 1 ratio on a glass coverslip
(Hirschmann Inc., KY, USA) to a thickness of about 25 μm
and curing at 70 °C for 40 min. The PDMS device was then
placed on top of the PDMS-covered coverslip and baked forThis journal is © The Royal Society of Chemistry 2014
f the microfluidic device containing a chemical gradient generator
(black arrow). Chemical solutions are delivered to the device by three
hes out from the middle one. (B) Detail of the branching and diffusional
the start of a new level of the gradient generator network. (C) Optical
Lab on a Chip Paper
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
4 
A
ug
us
t 2
01
4.
 D
ow
nl
oa
de
d 
on
 1
9/
12
/2
01
7 
12
:1
3:
49
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Onlineat least 2 h. The partial curing and the difference in curing
agent ratios ensure an irreversible, high-pressure-resistant
bonding.28 After curing, 20 ga metallic connectors (Instech)
were inserted into the access ports and 10 : 1 PDMS was
poured at the interface using a syringe and cured at 70 °C to
seal the connectors and prevent leakage.
Device operation
Prior to cell insertion, the device is first primed with 1% BSA
(w/w) in PBS to minimize the adherence of cells to the PDMS
surface along the channels. Cell seeding is performed by
flowing cells in medium through the cell inlet at a flow rate
of 0.5 μL min−1. The decision of when to stop cell insertion is
made independently for each device and takes into account
the number of single cells trapped and the number of cell
clusters accumulating in the first lines of traps. Our goal is to
maximize the former and minimize the latter. During cell
insertion, the medium is introduced at a flow rate of
0.4 μL min−1 through the solution inlets to prevent the back-
flow of cells and their accumulation in the inlets. We found
that if such backflow occurs, cells progressively detach from
the inlets and enter the cell chambers after the cell insertion
phase. This would bias the results since they would have
been exposed to a different chemical environment than
the previously trapped cells. Before starting the chemical
gradient generator, the cell inlet is plugged with a closed
metallic connector (Instech) to prevent fluid losses and possi-
ble biases in the gradient profile.
Syringes containing media are mounted into a syringe
pump (New Era Pump Systems, NY, USA) and connected to
the left, middle and right solution inlets – from lowest to
highest concentration of the chemical species of interest –
via polyethylene tubing (Instech).
Yeast strains and culture medium
In this work two yeast models of PD were used. The yeast
strain VSY72 (can1-100 his3-11 15 leu2-3 112 GAL1pr-
SNCA(WT)-GFP::TRP1 GAL1pr-SNCA(WT)-GFP::URA3 ade2-1)
carries two copies of the aSyn-GFP fusion inserted in the
genome under the control of the GAL1 inducible promoter
and was previously described.14 To study the formation of
aSyn inclusions we used the strain Y4791 (can1-100 his3-11
15 leu2-3 112 GAL1pr-SNCA(WT)-GFP::TRP1 GAL1pr-
SNCA(WT)-GFP::URA3 ade2-1).12 This strain harbors two
copies of WT aSyn and displays a stronger phenotype of toxic-
ity associated with the expression of aSyn than that of the
VSY72 strain. Cells were grown in synthetic complete (SC)
raffinose liquid medium (yeast nitrogen base without amino
acids, 6.7 g L−1; raffinose, 10 g L−1; CSM without uracil and
tryptophan as indicated by the supplier) for 24 h (doubling
time: ~3 h) at 30 °C with orbital agitation (200 rpm). Optical
density was measured at 600 nm (OD600 nm) and cells were
diluted in the same growth medium in order to be at the
exponential growth phase on the following day (with a final
OD600 nm around 1). OD600 nm was measured again and theThis journal is © The Royal Society of Chemistry 2014cells in suspension with an OD600 nm of 2 mL
−1 were collected
by centrifugation at 1800g at 30 °C for 5 min. Cells
were then washed in phosphate-buffered saline (PBS)
and resuspendend in PBS at a final OD600 nm of 1 mL
−1
(~1.5 × 107 cells mL−1). Before loading the cells into the device,
vigorous vortexing was applied to minimize cell clusters.
In the case of the treatment with ascorbic acid, Y4791
yeast cells were cultured for an additional 24 hours in SC
medium without uracil and tryptophan (SC–URA–TRP) and
with 1% GAL supplemented with 10 mM FeCl3.
Fluorescence microscopy
The acquisition of fluorescence signals during the tests for
the chemical gradient generator was made with a Leica
DMLM microscope equipped with a Leica DFC 300 FX digital
camera. Live-cell imaging and detection of the aSyn-GFP sig-
nal were done using a Zeiss Axiovert 200 M microscope
equipped with a motorized stage and a Roper Scientific
CoolSnap HQ CCD digital camera. Dry 20× and 40× Zeiss EC
Plan-Neofluar and oil 63× Zeiss Plan-Apochromat objectives
with numerical aperture values of 0.50, 0.75, and 1.40, respec-
tively, were used. Acquired images were analyzed using
ImageJ software (NIH, Bethesda, MD).
Results and discussion
Device description
The microfluidic device relies on two connected modules: a
chemical gradient generator and a set of 9 chambers each
containing hydrodynamic traps for yeast cells (Fig. 1A–C). The
chemical gradient generator has three inlets (solution inlets)
that allow the insertion of chemical solutions of different
compositions. A fourth inlet (cell inlet) branches out from the
middle solution inlet and is used to load the device with yeast
cells. The addition of this fourth inlet avoids the contamina-
tion of solution inlets. The channel connected to the cell inlet
is also equipped with a filter made of regularly spaced posts
to break or capture cell aggregates that could otherwise clog
the device or accumulate in the first line of cell traps.
The chemical gradient generator is composed of a multi-
level network of 50 μm wide, 9 μm high vertical serpentine-
shaped micro-channels where the mixing of chemical solu-
tions occurs. The first level is composed of the three
solution inlets followed by an array of four parallel serpen-
tine channels. At each subsequent level, the number of
serpentine channels is increased by one until reaching the
seventh level, which has nine serpentine channels. At the
end of each serpentine channel, the chemical solution is
split into two branches. Solutions stemming from adjacent
branches will then recombine and mix by flowing side by
side in the serpentine channels of the following level.
The micro-channels were shaped as serpentines to increase
their length while keeping the structure compact and to maxi-
mize the amount of time that the fluids remain in contact with
each other to ensure complete diffusive mixing. In this work,
all chemical gradients were generated by inserting chemicalLab Chip, 2014, 14, 3949–3957 | 3951
Fig. 2 Linearity and stability of the chemical gradient generated by
the microfluidic device. Normalized fluorescence signals of FITC
gradients generated by the microfluidic device and of a control
gradient produced by the manual dissolution of FITC in DIW (dotted
line). The microfluidic gradients were generated by inserting FITC at 0,
5 and 10 μg mL−1 (in DIW) at 0.3 μL min−1 in the left, middle and right
inlets, respectively. Fluorescence signals were acquired at t = 30 min
and t = 60 min (n = 2). The control gradient was prepared by manually
diluting FITC in DIW in 5 vials, producing solutions with FITC
concentrations of 0, 2, 5, 7.5 and 10 μg mL−1. The solutions were then
placed between two coverslips and the fluorescence signals were
acquired. Results shown are from two independent experiments.
Values are represented as mean ± SD.
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View Article Onlinesolutions through the 3 solution inlets simultaneously. By
mounting the syringes containing the solutions on a single
syringe pump we ensured that the flow rate was the same for
the 3 solution inlets. The flow rate used for generating chemi-
cal gradients was 0.3 μL min−1, resulting in an average fluid
velocity of 11.1 mm s−1 at the inlets, given the dimensions of
the channels. The serpentine channels have the same height
and width as the inlets and a total length of 11 mm, meaning
that the solutions inserted at 0.3 μL min−1 would take about
0.99 s to cross them. However, since the number of channels
increases at each level, the flow is split and the fluid velocity in
each channel is reduced. Since the serpentine channels only
appear at the second level of the structure (the first level being
composed of the three solution inlets), fluid flowing in the
serpentine channels always takes more than 0.99 s to cross
them – and this time increases in proportion to the level the
channel is in. Since for small molecules such as FITC, which
was used to calibrate the device (diffusion coefficient of
5 × 10−6 cm2 s−1), it takes 1 s to reach 97% diffusive mixing,25
we can say that the dimensions and flow rates used are appro-
priate to the generation of chemical gradients of small mole-
cules with comparable diffusion coefficients.
At the end of the serpentine channel, the fluid in the
micro-channel splits left and right in different proportions.
These splitting ratios depend on the level the channel is
in and its distance from the edges of the device.25 By multi-
plying the normalized splitting ratios of two streams
converging on a serpentine channel by the concentration of
the chemical solutions they carry, we can calculate the
chemical composition at the end of that channel. By iterat-
ing these calculations to each serpentine in each level, we
obtain the expected chemical composition in each of the
9 final chambers.24
The chemical gradient generating network ends in nine
final serpentine channels, each of which is connected to a
chamber containing an array of hydrodynamic cell traps. In
the schematic (Fig. 1A), we consider chamber 1 to be the first
from the bottom, and chamber 9 to be the last on the top.
The goal of connecting each chamber to a single serpentine
channel was twofold: (1) the chemical composition within a
given chamber is uniform since the chemical solutions are
completely mixed at the end of the serpentine channel; and
(2) the adjacent chambers have different chemical composi-
tions and represent the final gradient generated by the
microfluidic network. Each chamber is roughly 500 μm wide
and 1750 μm long and contains 506 traps disposed in a
checkerboard-like pattern. The cell traps are custom-sized
for yeast cells, and they consist of semicircular receptacles
with an internal diameter of 8 μm and a gap of 4 μm in
the middle (Fig. 1C). The gap allows liquid to flow when
the trap is empty but is blocked when a yeast cell is
trapped. The filling of this gap will re-route other incoming
cells' streamlines away from the occupied trap and into
neighboring traps. The dimensions of the traps must be
designed with a specific type of cell in mind in order to
accommodate the necessary physical dimensions.3952 | Lab Chip, 2014, 14, 3949–3957Efficacy of the chemical gradient generator
To determine the efficacy of the chemical gradient generator,
we started by testing the device using the fluorescent com-
pound fluorescein isothiocyanate (FITC). Aqueous solutions
with different concentrations of FITC (0, 0.5 and 10 μg mL−1)
were introduced through the solution inlets at a flow rate of
0.3 μL min−1, and the fluorescence signal produced was mea-
sured at the chambers located at the end of the generator
at t = 30 min and t = 60 min. The experiment was repli-
cated in two individual structures and the average and the
standard deviation of the FITC fluorescence signal per
chamber to assess the profile shape and stability were calcu-
lated. Due to the tendency of PDMS to adsorb small mole-
cules,29 all devices were primed with 1% bovine serum
albumin (BSA) in phosphate-buffered saline (PBS) prior to
the insertion of the test solutions.30 In parallel, as a control,
five vials were prepared with a manually made mixture of 0,
2.5, 5, 7.5 and 10 μg mL−1 FITC. These solutions were
sampled onto a microscope slide and fluorescence micros-
copy images were acquired. By comparing the signal inten-
sity in the different chambers, we verified that the profile of
the gradient produced by the generator was consistent with
theoretical predictions (Fig. 2). This means that by inserting
solutions in the device at concentration ratios of 0%, 50%
and 100% for the left, middle and right inlets, respectively,
where 100% represents the highest concentration of the
chemical species of interest, and 0% represents a solution
without the chemical species, we are able to generate a
linear gradient with a resolution dependent on the number
of channels at the end of the device. This allows us to cor-
relate a given chamber (bottom horizontal axis) with theThis journal is © The Royal Society of Chemistry 2014
Fig. 3 Trapping design and efficiency. (A) Influence of horizontal and
vertical spacing between traps (X and Y, respectively) in the capture of
single cells. Closer spaced traps were able to capture more cells, but
with a higher proportion of multiple-cell to single-cell trapping. Cells
were inserted at 0.5 μL min−1 for 30 min. (B) Bright-field optical micros-
copy image of hydrodynamic traps taken with a 20× objective in a
chessboard configuration. Traps can be empty (i) or occupied by a sin-
gle cell (ii) or by multiple cells (iii). The white arrow shows the 4 μm gap
that allows the passage of fluid when the trap is not occupied by a cell.
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View Article Onlineconcentration of the solution (top horizontal axis) (Fig. 2).
We also determined that the gradient was already stable
after 30 min, since no additional changes were observed
even after an additional 30 min (Fig. 2). Finally, we found
that the fluorescence signal did not increase linearly
with the concentration of FITC in both the microfluidic
gradient and the manual gradient. We identified a satura-
tion zone between 5 and 10 μg mL−1 FITC, suggesting that
this non-linearity may be due to self-quenching effects in
FITC that are unrelated to the device.
Cell trapping efficiency
The hydrodynamic traps presented in this device were
custom-designed for the particular yeast cells used in this
study. Optimization included the shape and the dimensions
of the trap (internal diameter, middle gap, horizontal and
vertical space between traps and the number of indentation
levels). In fact, we found that the spatial disposition of the
traps was an essential consideration, since traps that were
very densely distributed tended to capture more than a single
cell and would generate clustering in and around the traps.
This was due to the fact that larger cells or small aggregates
did not have enough room to be flushed from the cell
chamber, and this clustering could lead to the accumulation
of hundreds of cells at the first lines of traps, notwithstand-
ing the cell filter placed after the cell inlet. Since yeast cells
also tend to cluster in certain types of media, special con-
sideration was given to the ratio between the trapping of
individual cells and clusters. Thus, a compromise had to be
found between total trapping efficiency and trapped-single-
cell-to-trapped-aggregate ratio when designing the traps and
loading cells into the device. Although more densely packed
traps enabled the capture of more cells (86% for X = 20 μm,
Y = 10 μm compared to 62% for X = 20 μm, Y = 20 μm), the
proportion of single cells trapped was higher for more loosely
packed traps (39% for X = 20 μm, Y = 10 μm compared to 43%
for X = 20 μm, Y = 20 μm) (Fig. 3). Since the goal of this
platform was to maximize single-cell analysis, the spacing
of traps selected for the following studies was X = 20 μm and
Y = 20 μm.
Generation and characterization of the galactose gradient
Cells under perfusion in a microfluidic environment are
subjected to conditions different from that of a typical cell
culture, such as increased shear stress.21 To demonstrate that
the microfluidic conditions imposed by this device did not
alter the normal physiology of yeast cells, we tested the
response of the GAL promoter in a GAL gradient.
Cells were seeded in the device in medium with 1% RAF
and the gradient was generated by flowing media with (a)
1% RAF, (b) 0.5% RAF plus 0.5% GAL and (c) 1% GAL to
the left, middle and right solution inlets, respectively. Cells
were imaged by fluorescence microscopy (20× and 40× mag-
nification with an exposure of 100 ms) at sequential time
points after turning on the syringe pump, and the averageThis journal is © The Royal Society of Chemistry 2014fluorescence signal presented by at least 150 trapped cells
in each chamber was evaluated (Fig. 4A). At the 300 min
time point we observed that there was a clear increase
in the fluorescence signal in all chambers and that, as
expected, chambers with higher concentrations of GAL show
higher fluorescence signals (Fig. 4A, B). Although we
observed a steady increase in the fluorescence signal during
the first 3 time points in chambers containing GAL (cham-
bers 2 to 9), we found a sharp increase between t = 180 min
and t = 300 min. In fact, in some cases (chamber 8) the
signal intensity increased almost threefold between these
time points. This occurs because cells need time to adapt
and change their metabolic machinery in order to use GAL
as a carbon source, resulting in the induction of aSyn-GFP
expression. The signal increase was linear between chamber 1
and chamber 6, after which it reached a plateau corre-
sponding to a GAL concentration between 0.6% and 0.8%.
This demonstrates the usefulness of this structure, as we are
able to identify with very high resolution the GAL concentra-
tion at which the production of aSyn saturates.
Furthermore, we also observed budding of yeast cells
(Fig. 4B) throughout the course of the experiment (5 hours),
indicating that cells were progressing through the cell cycle
and demonstrating that normal physiology was maintained
under the microfluidic conditions used.
Individual response of cells to galactose
It is virtually impossible to track single cells in a suspension
without the use of labels or reporter genes. In the microfluidic
device developed in this work, cells remain immobilized in
the traps throughout the duration of the experiment. There-
fore, it is possible to monitor individual cell responses to
stimuli over time without the specific need for using cell
labels. To investigate the phenotypic variability of individual
cells in the population upon GAL induction, we analyzed theLab Chip, 2014, 14, 3949–3957 | 3953
Fig. 4 Yeast response to a linear galactose gradient. (A) Normalized mean fluorescence signal of aSyn-GFP in yeast cells over time when exposed
to a linear concentration gradient of GAL (n = 150 for each chamber). The gradient was generated by introducing the medium in the left, middle
and right inlets of the microfluidic device at 0.3 μL min−1 and supplemented with concentrations of 1% RAF and 0.5% RAF plus 0.5% GAL and 1%
GAL, respectively. Values represent mean ± SD. (B) Fluorescence microscopy images of trapped cells. The first series of images (left) shows
an increase in fluorescence signal in chamber 9 (CGAL = 1.00%) throughout the time points, with a noticeable increase between t = 180 min and
t = 300 min. The second series of images (right) shows that the fluorescence signal at t = 300 min is stronger for higher CGAL. Budding of cells,
noticeable at t = 300 min on both series, is a clear sign of normal physiology.
Lab on a ChipPaper
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
4 
A
ug
us
t 2
01
4.
 D
ow
nl
oa
de
d 
on
 1
9/
12
/2
01
7 
12
:1
3:
49
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Onlinebehavior of 35 individual cells trapped in chamber 9 and evalu-
ated the production of aSyn-GFP. We found that individual
cells exposed to the same chemical environment displayed a
broad range of expression of aSyn-GFP (Fig. 5A). By analyzing
the normalized fluorescence signal after 300 min, we observed
a normal distribution of the signal with a mean value of
49 ± 18 (SD) (Fig. 5B). This dispersion allowed us to determine
not only the minimum and maximum values of the fluores-
cence signal emitted by the cell population after 300 min3954 | Lab Chip, 2014, 14, 3949–3957
Fig. 5 Individual cells within the same population respond differently to th
signal of one of 35 individual cells in chamber 9 (CGAL = 1.00%) for t =
area shows the dispersion of the fluorescence signal emitted by the c
widely different behaviors when exposed to the same chemical stimulus
signals of 4.91 at t = 30 min and 18.01 at t = 300 min is shown by the whit
t = 300 min is shown by the black arrow. The fluorescence microscopy im
(middle) and minimum signal (bottom) observed at t = 300 min. (B) Th
population of chamber 9 at t = 300 min follows a normal distribution with m(10.64 and 100.00, respectively) but also how it evolved over
time (Fig. 5A, grey area). As an example, we show a cell with
fluorescence signals of 4.91 at t = 30 min and 18.01 at t = 300
min, and another cell with signal values of 1.43 at t = 30 min
and 54.45 at t = 300 min, showing that the production of aSyn
can vary greatly from cell to cell within a given population
(Fig. 5A). Examples of this phenomenon have already been
reported in different types of isogenic cells, from bacteria31 to
adherent mammalian cells under microfluidic conditions.32This journal is © The Royal Society of Chemistry 2014
e same stimulus. (A) Each line represents the normalized fluorescence
30, 60, 120, 180, 240, and 300 min in a single experiment. The grey
ells, indicating that within a given population individuals can have
. Two examples of this dispersion are given: a cell with fluorescence
e arrow, and a cell with signal values of 1.43 at t = 30 min and 54.45 at
ages (left) show three cells representing the maximum (top), average
e fluorescence signal intensity of the 35 individual cells within the
ean ± SD of 49 ± 18.
Fig. 6 Chemical stressor FeCl3 induces aSyn inclusion formation
in yeast. Percentage of cells presenting aSyn-GFP inclusions in the
cytoplasm when exposed to a gradient of FeCl3 diluted in medium for
24 h. The percentage for each chamber was calculated by dividing the
sum of the cells with inclusions in three experiments by the number of
cells without inclusions in the same three experiments. The lower
XX axis represents the microfluidic chamber in which the measure-
ments were done and the upper XX axis represents the predicted
concentration of FeCl3 given the initial solution concentrations and the
linearity of the microfluidic gradient generator.
Fig. 7 Ascorbic acid reduces aSyn inclusion formation in yeast.
Percentage of cells with aSyn-GFP inclusions in the cytoplasm after a
24 h exposure to a gradient of ascorbic acid (AA). Y4791 cells were
previously exposed to medium containing 1% GAL and 10 mM FeCl3
for 24 h. Before introduction of cells into the device, the proportion
of cells with inclusions was 90% (horizontal dotted line). The lower
XX axis represents the microfluidic chamber in which the measure-
ments were done and the upper XX axis represents the predicted con-
centration of ascorbic acid given the initial solution concentrations
and the linearity of the microfluidic gradient generator.
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View Article OnlineThis highlights the advantage of our device, enabling the study
of individual cells in a population over time.
By studying the distribution of aSyn production in single
cells we are able to further characterize this cell model. In
addition, our approach will enable future studies on cells
displaying above or below average responses and the assess-
ment of the mechanisms behind increased sensitivity or
resistance to the stimuli of choice. Also, by isolating a given
cell we could directly observe the increase in the production
of aSyn-GFP throughout the duration of the experiment
(Fig. 5A), which allowed us to study not only the kinetics of
aSyn-GFP formation and degradation but also the effects of
changing the chemical environment on a single cell. By using
techniques such as 4D imaging, we would also be able to
use this device to pinpoint with very high spatial accuracy
the appearance and evolution of aSyn accumulation and
inclusion formation.
FeCl3 induces the formation of aSyn inclusions in a
concentration-dependent manner
After establishing the suitable functioning of the gradient
generator and that cells responded to chemical stimuli in the
microfluidic environment of our device, we set out to investi-
gate the effects of oxidants and antioxidants in the formation
of aSyn inclusions in yeast. FeCl3 was chosen as the chemical
stressor since it has been previously reported to induce the
formation of aSyn inclusions in yeast.33 For this experiment,
yeast cells expressing aSyn-GFP (Y4791 strain) were trapped
in the device, exposed to a gradient of FeCl3 with concentra-
tions ranging from 0 to 10 mM for 24 hours and imaged
using fluorescence microscopy (63× objective and 50 ms
exposure). For that end, a gradient was generated using a
medium containing 1% GAL supplemented with 0, 5 and
10 mM FeCl3. Due to the variability in the number of cells
available for analysis per chamber across the three tested
devices, we chose to analyze the three samples as a whole
and not individually, i.e., average and standard deviation
with n = 3 for each chamber. As such, for each chamber,
we calculated the percentage of cells with inclusions by
dividing the sum of cells with inclusions identified across
the three devices by the total number of cells analyzed. We
observed a linear increase in the percentage of cells
displaying aSyn inclusions with increasing concentrations of
FeCl3 (from 27% at 0 mM to 96% at 10 mM) (Fig. 6), dem-
onstrating that oxidative stressors can promote the accumu-
lation of aSyn inclusions in yeast. It should be noted that
the controlled induction of aSyn inclusions through chemi-
cal stressors is an important tool for studying aSyn toxicity.
Ascorbic acid reduces the formation of aSyn inclusions
Oxidation is an important mechanism in the aggregation of
aSyn.12,15,34,35 Moreover, aSyn expression itself increases
oxidative stress by promoting the accumulation of reactive
oxygen species (ROS).34,36 Therefore, compounds that reduce
oxidative stress could protect cells from aSyn-inducedThis journal is © The Royal Society of Chemistry 2014damage. Among other compounds, ascorbic acid (AA) reacts
with toxic ROS and renders them non-toxic. AA was reported
to counteract the oligomerization of aSyn induced by FeCl2 in
neuronal cells overexpressing aSyn.34 Thus, we selected this
compound to determine whether it could modulate aSyn
inclusion formation in yeast. To test this, yeast cells express-
ing aSyn-GFP (Y4791 strain) were grown in GAL medium with
10 mM FeCl3 for 24 hours. Cells were then exposed to a gra-
dient of AA and individual cells were followed by fluorescence
microscopy and the percentage of cells containing inclusions
was calculated, as described above. In the absence of AA
(chamber 1), the percentage of cells displaying aSyn inclu-
sions was rather high (~90%) (Fig. 7). However, withLab Chip, 2014, 14, 3949–3957 | 3955
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View Article Onlineincreasing concentrations of AA we observed a linear
decrease in the percentage of cells with inclusions, decreas-
ing to 32% at 20 mM AA.
We hypothesize that the effect of AA on aSyn inclusion
formation might be either by preventing the formation of
new inclusions or by promoting the clearance of preformed
inclusions, but this needs to be further investigated in subse-
quent studies. Nevertheless, our results clearly demonstrate
the usefulness of this microfluidic platform as a tool to test
compounds of interest with unparalleled resolution.Conclusions
This work was aimed at studying aSyn biology using micro-
fluidic technology in order to obtain single-cell resolution
within entire cell populations. This was achieved by
connecting chambers with arrays of hydrodynamic traps that
immobilize cells at the end of a microfluidic chemical gradi-
ent generator. The immobilization of non-adherent cells, the
control of their microenvironment and the creation of a
chemical gradient with a small number of initial solutions
are the main features that set this device apart from conven-
tional bulk systems such as Petri dishes and well plates. The
trapping of cells is paramount for this type of high-resolution
studies, since it guarantees that we can track a single cell's
response over time. In this way, we can choose to study either
the kinetics of a stimulus in the steady state – in the case of
the GAL gradient we were able to pinpoint the moment where
aSyn production peaked – or the response of cells to a
dynamically changing chemical environment. This approach
is not possible in bulk systems since non-adherent cells are
usually cultured in suspension and most adherent cells are
able to migrate, making it impossible to track a single cell
without the use of reporter molecules.
The gradient generator, the other main feature of this
device, also represents an improvement to classical cell cul-
ture techniques as it allows for the creation of a chemical gra-
dient of customizable resolution with just three initial
solutions, which is simpler, quicker and less error-prone than
the manual mixing of solutions. Moreover, it allows one to
dynamically alter the gradient profile by changing either the
initial solutions or the relative flow rates in each channel.
Whereas in bulk systems the exposure of a cell population to
a different chemical stimulus would imply removing the
medium, rinsing and inserting a new solution, in this system
this change can be made seamlessly by simply changing the
solution-containing syringes. Furthermore, the combination
of cell trapping and perfusion allows a given cell – or a popu-
lation of cells – to be exposed to a constant microenviron-
ment, with a constant supply of nutrients and flushing of
metabolites, all the while remaining immobilized and avail-
able for imaging – something that in conventional cell cul-
ture is only possible with bulky and expensive perfusion
systems. In the context of cell assays under perfusion condi-
tions, it should also be added that to perform any of the3956 | Lab Chip, 2014, 14, 3949–3957experiments described, we require just three 1 mL syringes
containing the chemicals of interest.
We focused on exposing populations of yeast cells express-
ing aSyn-GFP to highly controlled yet chemically different
environments. As previously explained, this device also has
the added benefit of allowing the chemical environment to
be changed dynamically, allowing cells to be exposed to a
sequence of chemical species of interest, such as oxidants
and antioxidants. In doing so, we targeted applications where
rapid, parallel analysis of aSyn expression levels and location
is needed, e.g., for characterizing the effect of the complex
and the sequential exposure of the cellular model to solu-
tions with different chemical compositions of interest. To
approach these goals, we anticipate further research towards
(i) integrating an array of microsensors into the chip at the
cell trap locations, able not only to follow the fluorescence
of different fluorophores in individual whole cells, but also,
desirably, to map the spatial distribution of fluorescence
in each cell in real time; (ii) improving cell handling to allow
precise on-chip cell collection after sequential exposure for
further experiments, namely, genetic expression profiling;
and (iii) understanding how the knowledge of single-cell vari-
ability can impact our understanding of PD pathology, given
that specific populations of neuronal cells appear to show
different susceptibility to aSyn or chemical toxins. Eventually,
advanced microfluidic cell-chip devices will enable us to
develop systems that facilitate the development of novel
in vitro disease models that recapitulate the molecular under-
pinning of the human disease more reliably, potentiating the
discovery of novel therapeutic or diagnostic strategies.
Although in this study we explored this device for our
specific interest in aSyn pathobiology, it is important to men-
tion that the system developed here is readily adaptable to
studies involving other proteins. In fact, yeast cells are
unquestionable powerful models to dissect the basic molecu-
lar mechanisms underlying PD and other neurodegenerative
diseases,3 as well as other human diseases such as mitochon-
drial diseases,37 cancer,2 and calcium-related diseases,38
among others. Yeast models have also been very useful to iden-
tify new compounds with therapeutic interest through high-
throughput screening approaches39,40 as well as to identify the
molecular basis of the action of pharmacologically active
molecules.41,42
This device is also adaptable to studies using other cell
types, requiring eventually minor adjustments in the design.
There are also advantages for studies employing adherent
cells since the trapping allows placing them in pre-
determined sites on the chip, prevents cell–cell communica-
tion if single cells are captured and avoids potential flushing
of cells under perfusion conditions.23 If required, the resolu-
tion of the gradient, i.e. the concentration intervals, can be
easily increased by adding extra levels and chambers to the
device. Finally, bidimensional or more complex gradients,
where two different compounds would be inserted through
the solution inlets to study synergistic effects, are another
interesting and innovative application for this device, withThis journal is © The Royal Society of Chemistry 2014
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View Article Onlinethe extra advantage that only very small volumes of the test-
ing compounds would be required. In total, our study not
only provides novel information on the biology of aSyn but
also expands the toolbox for investigating biological pro-
cesses of interest with unprecedented resolution.
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